Aetna Inc. (AET) Position Lowered by Dynamic Technology Lab Private Ltd
Dynamic Technology Lab Private Ltd lessened its position in shares of Aetna Inc. (NYSE:AET) by 35.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,400 shares of the company’s stock after selling 1,908 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in Aetna were worth $516,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bruderman Asset Management LLC purchased a new stake in Aetna during the 2nd quarter worth approximately $106,000. Liberty Capital Management Inc. grew its position in Aetna by 206.9% during the 2nd quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after purchasing an additional 629 shares during the last quarter. Guardian Life Insurance Co. of America grew its position in Aetna by 0.7% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after purchasing an additional 9 shares during the last quarter. Westside Investment Management Inc. grew its position in Aetna by 53.5% during the 2nd quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock worth $177,000 after purchasing an additional 400 shares during the last quarter. Finally, Deschutes Portfolio Strategy LLC purchased a new stake in Aetna during the 2nd quarter worth approximately $200,000. Hedge funds and other institutional investors own 89.52% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This story was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://www.watchlistnews.com/aetna-inc-aet-position-lowered-by-dynamic-technology-lab-private-ltd/1649333.html.
In other news, EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the completion of the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction on Monday, September 18th. The stock was sold at an average price of $161.91, for a total value of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by insiders.
AET has been the topic of several research analyst reports. Citigroup Inc. initiated coverage on shares of Aetna in a research report on Wednesday, June 28th. They set a “buy” rating and a $180.00 target price on the stock. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $170.00 target price on the stock in a research report on Tuesday, July 4th. Credit Suisse Group reissued an “outperform” rating and set a $165.00 target price (up previously from $160.00) on shares of Aetna in a research report on Thursday, July 13th. Deutsche Bank AG boosted their target price on shares of Aetna from $144.00 to $157.00 and gave the stock a “hold” rating in a research report on Thursday, July 13th. Finally, BidaskClub downgraded shares of Aetna from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Nine equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $161.83.
Aetna Inc. (NYSE:AET) opened at 160.84 on Monday. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $164.52. The firm has a market capitalization of $53.41 billion, a PE ratio of 35.70 and a beta of 0.53. The firm’s 50-day moving average is $158.22 and its 200-day moving average is $149.92.
Aetna (NYSE:AET) last issued its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping the consensus estimate of $2.34 by $1.08. The company had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business’s revenue was down 2.7% on a year-over-year basis. During the same period in the previous year, the firm earned $2.21 EPS. On average, analysts anticipate that Aetna Inc. will post $9.52 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, October 12th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, October 11th. This represents a $2.00 annualized dividend and a dividend yield of 1.24%. Aetna’s payout ratio is currently 43.67%.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.